APA

Ombetta J., Thelier N., Dong C. Z., Plocki S., Tsagris L., Rannou F., Massicot F., Djimdé A., El-Hayek E., Shi Y., Heymans F., Gresh N. & Chauvet C. (20100901). Design of group IIA secreted/synovial phospholipase A(2) inhibitors: an oxadiazolone derivative suppresses chondrocyte prostaglandin E(2) secretion. : PloS one.

Chicago

Ombetta Jean-Edouard, Thelier Natacha, Dong Chang Zhi, Plocki Stéphanie, Tsagris Lydia, Rannou François, Massicot France, Djimdé Atimé, El-Hayek Elissar, Shi Yiming, Heymans Françoise, Gresh Nohad and Chauvet Caroline. 20100901. Design of group IIA secreted/synovial phospholipase A(2) inhibitors: an oxadiazolone derivative suppresses chondrocyte prostaglandin E(2) secretion. : PloS one.

Harvard

Ombetta J., Thelier N., Dong C. Z., Plocki S., Tsagris L., Rannou F., Massicot F., Djimdé A., El-Hayek E., Shi Y., Heymans F., Gresh N. and Chauvet C. (20100901). Design of group IIA secreted/synovial phospholipase A(2) inhibitors: an oxadiazolone derivative suppresses chondrocyte prostaglandin E(2) secretion. : PloS one.

MLA

Ombetta Jean-Edouard, Thelier Natacha, Dong Chang Zhi, Plocki Stéphanie, Tsagris Lydia, Rannou François, Massicot France, Djimdé Atimé, El-Hayek Elissar, Shi Yiming, Heymans Françoise, Gresh Nohad and Chauvet Caroline. Design of group IIA secreted/synovial phospholipase A(2) inhibitors: an oxadiazolone derivative suppresses chondrocyte prostaglandin E(2) secretion. : PloS one. 20100901.